A detailed history of Nisa Investment Advisors, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 163 shares of LQDA stock, worth $1,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
163
Previous 105 55.24%
Holding current value
$1,735
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$8.9 - $14.11 $516 - $818
58 Added 55.24%
163 $1,000
Q2 2024

Jul 19, 2024

BUY
$11.96 - $15.71 $334 - $439
28 Added 36.36%
105 $1,000
Q1 2024

May 01, 2024

BUY
$11.35 - $16.73 $578 - $853
51 Added 196.15%
77 $1,000
Q4 2022

Feb 02, 2023

BUY
$4.68 - $6.54 $121 - $170
26 New
26 $0
Q4 2020

Jan 25, 2021

SELL
$2.6 - $5.79 $8,580 - $19,107
-3,300 Closed
0 $0
Q2 2020

Jul 27, 2020

BUY
$4.86 - $11.44 $9,720 - $22,880
2,000 Added 153.85%
3,300 $28,000
Q1 2020

Apr 17, 2020

BUY
$3.31 - $7.15 $4,303 - $9,295
1,300 New
1,300 $6,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $685M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.